For Science! 🧬🦠🧫🔬💉
🎨: @Boltie_ Image
Marten Microbiology is a new panel series (along with Q&A sessions) I will be running at conventions I attend. Let’s talk about viruses, vaccines, and so much more! Stay tuned here for announcements and be sure to check convention programming details!
First up will be @BewhiskeredCon this Friday November 12th, 2021 at 7:30pm EST. I will be attending as a GoH! Registration is already sold out but don’t worry, it will be recorded and streamed!
Next will be @FurFest on December 4th, 2021 at 1:00pm CST. Second Stage, Donald E. Stephens Convention Center, Second Floor. Hope to see you there! I will record and stream this, so if you cannot make it, don’t fret!
Going to @AnthroExpo in January 2022? I will be attending as GoH! Just a reminder that pre-registration is still open with all kinds of perks and ends on December 1st. You can find more information here: AnthroExpo.net. Once I have the scheduled date/time I’ll update.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Chise 🧬🧫🦠💉🔜 BWS GoH

Chise 🧬🧫🦠💉🔜 BWS GoH Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @sailorrooscout

10 Nov
It is a GREAT morning when you find studies that can help put to rest concerns about AY.4.2, B.1.617.2+E484K, AY.1, AY.2 (or rather “Delta-Plus” in general) Lambda, B.1.1.519, A.30, Mu and so much more.

When I say the vaccines can handle variants I mean it. Working on a thread.
A recent study out Denmark shows a sublineage of the Delta variant, AY.4.2, was NOT more resistant to neutralization relative to other circulating Delta lineages or sublineages AND showed ONLY a MODEST 2.3-fold reduction in neutralization.

Let’s talk about that and more!
AY.4.2 recently accounted for an increase proportion of Delta cases in United Kingdom (UK), Romania, Poland, and Denmark. Here, researchers evaluated the sensitivity of AY.4.2 to neutralization by sera from Pfizer recipients. AY.4.2 was NOT more resistant to neutralization
Read 14 tweets
8 Nov
If you see the claim that there are currently 14X more COVID-19 patients in UK hospitals than this time last year, that is blatant MISINFORMATION at best. There were 14,546 hospitalized COVID-19 patients a year ago (November 8, 2020), and 9,160 today.
You can easily go on the UK Coronavirus Dashboard. The information is right at your fingertips. coronavirus.data.gov.uk/details/health…. Misinformation or just downright blatant lies doesn’t help promote vaccine uptake, if anything it promotes hesitancy.
What is important to know, and can be seen when comparing last year to where we are currently is that the vaccines are highly effective in preventing severe disease, hospitalization, and death due to COVID-19 even in the face of the Delta variant.
Read 5 tweets
7 Nov
Just a friendly reminder. Despite what you might hear, there has yet to be a variant that isn’t susceptible to the vaccines.
Why are variants unlikely to FULLY evade vaccine-induced immunity?
•Vaccines are polyclonal
•CD8+ T-cells covering 52 epitopes across the spike protein
•CD4+ T-cells covering 23 epitopes across the spike protein
You can learn about epitopes here: news-medical.net/life-sciences/…
Regarding the concerns about waning immunity. Please remember, this is likely referring to infection. Not effectiveness against symptomatic infection, not effectiveness against severe illness. See: bmj.com/content/374/bm…
Read 9 tweets
5 Nov
FANTASTIC news for your Friday! Phase 2/3 results of PAXLOVID, Pfizer’s COVID-19 oral antiviral shows the risk of hospitalization or death is REDUCED by NEARLY 90% in high-risk adults with COVID-19 when taken within three days of experiencing symptoms.

Let’s talk about that! 🧵
IMPORTANT NOTE: this protease inhibitor was originally developed for SARS-CoV in 2003 and has been repurposed! So first, let’s discuss the results. The scheduled interim analysis showed an 89% reduction in risk of COVID-19-related hospitalization or death from any cause compared
to placebo in patients treated within three days of symptom onset (primary endpoint); 0.8% of patients who received PAXLOVID™ were hospitalized through Day 28 following randomization (3/389 hospitalized with NO deaths), compared to 7.0% of patients who received placebo and
Read 14 tweets
3 Nov
How’s your morning going? Image
This is how I started my birthday.
Update. The Dinosaur- I mean, uh, the bird has been successfully contained.
Read 4 tweets
2 Nov
“The vaccines don’t work- look at Singapore.” Alright, let’s.

Cases are at record highs due to Delta, however, ALMOST 99% of Singapore’s vaccinated cases are MILD or have NO symptoms. In addition, the nation has had VERY FEW deaths despite a surge in cases.

I’m not done.🧵
Almost 84% of Singapore’s population is considered to be fully vaccinated. IMPORTANT TO NOTE: Singapore transitioned away from a ZERO COVID approach. The rise in cases upon attempting to reopen was to be expected as part of attempting to “live” with the virus and reopen.
According to their MOH, over the last 28 days, of the 96,376 infected individuals, 98.7% are MILD or have NO symptoms, 0.8% required oxygen supplementation, 0.3% required ICU care, and 0.2% had died. moh.gov.sg/news-highlight…
Read 14 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(